A more complete DHT blocker than finasteride, with a smaller, though growing, evidence base for hair.
BModerate evidence · often off-label for hair
Dutasteride inhibits both type-I and type-II 5α-reductase, suppressing more DHT than finasteride. Head-to-head trials suggest greater regrowth, but the trial base is smaller and much use is off-label. It is a stronger version of the same brake, with the same structural limit: it does not restart dormant follicles.
Grades for hair treatments change. Know when they do. Get an alert when a grade moves, plus each new review. About 2 emails a month. No products, no sponsors.
By hitting both enzyme isoforms, dutasteride drops serum and scalp DHT further than finasteride. Comparative trials, mostly in men, several from single regions, report modestly better hair counts, which earns a B rather than an A: the direction is consistent, the independent replication is still thinner.
Its longer half-life and broader androgen effect also mean a wider side-effect consideration, and it carries the same pregnancy contraindications as finasteride.
Read honestly: a legitimate escalation for men who plateau on finasteride, under medical guidance. Still a defensive move. The complementary, non-hormonal lever, supplying the growth signal, sits with the growth factors.

